How much does the targeted drug Lorlatinib cost?
Lorlatinib is a new generation targeted therapy drug for the treatment of ALK (ectopic lymphoma kinase)-positive non-small cell lung cancer (NSCLC). ALKpositiveNSCLC is a specific subtype of lung cancer, accounting for about 5-7% of NSCLC patients. Lorlatinib was developed to address patients who have developed resistance to traditional ALK inhibitors.
Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Lorlatinib, as a tyrosine kinase inhibitor, inhibits the growth and spread of cancer cells by blocking the activity of ALK protein. Compared with some previous ALK inhibitors, lorlatinib is designed to be more specific and can inhibit multiple mutants simultaneously, including those that are resistant to other drugs.
The drug has shown good efficacy in clinical trials, especially in the treatment of patients with a high diversity of ALK mutants and strong drug resistance. Lorlatinib has also been shown to be able to cross the blood-brain barrier, so it also shows good results in the treatment of brain metastases NSCLC, providing patients with a more comprehensive treatment option.
However, like any drug, lorlatinib may cause a range of side effects, including but not limited to nausea, fatigue, high blood pressure, etc. Therefore, before using lorlatinib, doctors need to fully evaluate the patient's condition and physical condition to ensure an appropriate treatment plan.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)